Axovia teams with Viralgen to manufacture BBS gene therapy
Contract development manufacturing organization (CDMO) Viralgen and biopharmaceutical developer Axovia Therapeutics have partnered to develop and manufacture AXV-101, an investigational gene therapy for treating retinal dystrophy in patients with Bardet- …